Agile Therapeutics (AGRX) PT Raised to $5 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell raised the price target on Agile Therapeutics (NASDAQ: AGRX) to $5.00 (from $4.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
